Core Viewpoint - China's first prospective clinical trial of an invasive brain-computer interface (BCI) has been successfully conducted, making it the second country globally to enter the clinical trial phase after the United States [1] Group 1: Clinical Trial Details - The clinical trial's subject is a 37-year-old male who lost his limbs due to a high-voltage accident. Since the implantation of the BCI device in March, the system has operated stably without infections or electrode failures for over a month [3] - The subject has achieved a level of control over a computer touchpad comparable to that of a normal person, allowing him to play chess and racing games using only his thoughts after 2-3 weeks of adaptive training [3] Group 2: Technological Advancements - The implanted device is the smallest brain-controlled implant globally, measuring 26mm in diameter and less than 6mm in thickness, which is half the size of Neuralink's product [8] - The flexible neural electrodes developed by the research team are 1/5 to 1/7 the cross-sectional area of those used by Neuralink, providing better compatibility with brain tissue and reducing damage [5] Group 3: Research and Development - The research team has established a comprehensive approach to BCI research, covering various aspects such as motion perception, neural function repair, decoding algorithms, and wireless system development since 2022 [5] - The dynamic optimization of the neural decoder has been achieved through an online learning framework, allowing real-time motion decoding and overcoming the limitations of traditional static decoding models [9] Group 4: Future Prospects - The BCI system is expected to improve the quality of life for patients with complete spinal cord injuries, double upper limb amputations, and amyotrophic lateral sclerosis by enabling them to control external devices [12] - Future trials will aim to allow the subject to use robotic arms for physical tasks, expanding the potential applications of the technology [12]

Group 1 - The China (Shanghai) International Technology Import and Export Fair, held from June 11 to 13, serves as a national and international platform for showcasing advanced technologies and facilitating innovation resource connections [3][8] - This year's fair features 14 enterprises and institutions launching new products and technologies, with 7 of them being global or national debuts [3][4] - The event includes four specialized technology exhibition areas and covers a total exhibition area of 35,000 square meters [3] Group 2 - The "Lunar Soil Fiber" technology, developed by Donghua University, aims to convert lunar soil into high-performance fiber materials, which could be used for constructing lunar bases [4][6] - The fair highlights various innovative technologies, including a wireless invasive brain-machine interface system from JieTi Medical, which is designed to assist patients with severe motor function impairments [6][7] - Wuhan New Water Environmental Technology Co., Ltd. presents a bio-enzyme nano-robot technology that effectively decomposes algae and monitors water quality using IoT and big data [7][8] Group 3 - The Shanghai Technology Contract Registration reached 53,864 items in 2024, with a transaction amount of 520.073 billion yuan, marking a 6% and 7.2% increase respectively from the previous year [8] - The fair's technology transfer zone features multiple "technology matchmaker" professionals providing services to facilitate technology transfer and commercialization [9][12] - The event aims to enhance the commercialization of scientific research and technology transfer, with various specialized institutions offering comprehensive support for project development [12][13]